Skip to main content

Table 4 Results of the SureX HPV test and Venus HPV test by histopathological category

From: Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening

  Total (%) SureX HPV Venus HPV P value
Positive (%) Negative (%) Positive (%) Negative (%)
Total 290 (100%) 227 (78.3) 63 (21.7) 227 (78.3) 63 (21.7) 1.00
Histological category       
Normal 33 (11.4) 11 (33.3) 22 (66.7) 12 (36.4) 21 (63.6) 0.796
CIN1 56 (19.3) 28 (50.0) 28 (50.0) 30 (53.6) 26 (46.4) 0.705
CIN2 28 (9.7) 25 (89.3) 3 (10.7) 25 (89.3) 3 (10.7) 1.00
CIN3 35 (12.1) 34 (97.1) 1 (2.9) 30 (85.7) 5 (14.3) 0.088
CAa 138 (47.6) 130 (94.2) 8 (5.8) 130 (94.2) 8 (5.8) 1.00
  1. aCA includes adenocarcinoma in situ (ACIS), squamous cell carcinoma (SCC), adenocarcinoma (AC) and adenosquamous carcinoma (ASC)
\